| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
3 and GlcNAc:ß1
-4 Galactosyltransferase Activities between Human Colonic Adenocarcinomas and Normal Colonic Mucosa1
Department of Biochemistry, Sasaki Institute, 2-2, Kanda-Surugadai, Chiyoda-ku, Tokyo 101 [A. S., T. O., K. Y.], and Second Department of Pathology, Kagoshima University School of Medicine, 8-35-1 Sakuragaoka, Kagoshima City 890 [H. K., S. Y., E. S.], Japan
The activities of GlcNAc:ß1
3 and GlcNAc:ß1
4 galactosyltransferases in normal human colonic mucosa and well or moderately differentiated colonic adenocarcinomas and their enzyme-kinetic characteristics were investigated. After UDP-[3H]galactose and N-linked type monoantennary oligosaccharides (GlcNAcß1
2Man
1
3(6)Manß1
4GlcNAc) had been incubated with microsome fractions prepared from these tissues, the synthesized [3H]galactose-labeled oligosaccharides were analyzed by Ricinus communis agglutinin-I agarose chromatography, Streptococcus 6646K ß-galactosidase, Galß1
4-specific diplococcal ß-galactosidase, and Galß1
3GlcNAc-specific lacto-N-biosidase digestion. The ß-galactosyltransferases from normal mucosa synthesized both type 1 and type 2 chains at comparable levels, whereas those from adenocarcinomas predominantly synthesized type 2 chains. To our knowledge, this is the first quantitative estimation of GlcNAc:ß1
3 galactosyltransferase activity toward N-linked sugar chains. Furthermore, we compared the two galactosyltransferase activities in 10 normal mucosa and adenocarcinoma samples and found that while there existed similar levels of GlcNAc:ß1
4 galactosyltransferase activity in normal mucosa and adenocarcinomas, GlcNAc:ß1
3 galactosyltransferase activity apparently decreased from 0.67 ± 0.26 (normal mucosa) to 0.18 ± 0.11 nmol/min/mg of protein (adenocarcinomas). These results are consistent with those of comparative structural studies on N-linked sugar chains of carcinoembryonic antigen and its normal counterparts and suggest that in the process of differentiated carcinogenesis of human colonic tissues, the expression of GlcNAc:ß1
3 galactosyltransferase is negatively regulated.
1 This work was supported by special funds from the Science and Technology Agency of the Japanese government and by funds from the Central Research Institute of Fukuoka University, Japan.
2 To whom requests for reprints should be addressed.
Received 3/19/96. Accepted 5/31/96.
This article has been cited by other articles:
![]() |
S. Isshiki, T. Kudo, S. Nishihara, Y. Ikehara, A. Togayachi, A. Furuya, K. Shitara, T. Kubota, M. Watanabe, M. Kitajima, et al. Lewis Type 1 Antigen Synthase ({beta}3Gal-T5) Is Transcriptionally Regulated by Homeoproteins J. Biol. Chem., September 19, 2003; 278(38): 36611 - 36620. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seko, N. Dohmae, K. Takio, and K. Yamashita beta 1,4-Galactosyltransferase (beta 4GalT)-IV Is Specific for GlcNAc 6-O-Sulfate. beta 4GalT-IV ACTS ON KERATAN SULFATE-RELATED GLYCANS AND A PRECURSOR GLYCAN OF 6-SULFOSIALYL-LEWIS X J. Biol. Chem., March 7, 2003; 278(11): 9150 - 9158. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. El-Fasakhany, K. Ichihara-Tanaka, K. Uchimura, and T. Muramatsu N-Acetylglucosamine-6-O-Sulfotransferase-1: Production in the Baculovirus System and Its Applications to the Synthesis of a Sulfated Oligosaccharide and to the Modification of Oligosaccharides in Fibrinogen J. Biochem., March 1, 2003; 133(3): 287 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kumamoto, Y. Goto, K. Sekikawa, S. Takenoshita, N. Ishida, M. Kawakita, and R. Kannagi Increased Expression of UDP-Galactose Transporter Messenger RNA in Human Colon Cancer Tissues and Its Implication in Synthesis of Thomsen-Friedenreich Antigen and Sialyl Lewis A/X Determinants Cancer Res., June 1, 2001; 61(11): 4620 - 4627. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seko, J.-i. Sumiya, S. Yonezawa, K. Nagata, and K. Yamashita Biochemical differences between two types of N-acetylglucosamine:->6sulfotransferases in human colonic adenocarcinomas and the adjacent normal mucosa: specific expression of a GlcNAc:->6sulfotransferase in mucinous adenocarcinoma Glycobiology, September 1, 2000; 10(9): 919 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kolbinger, M. B. Streiff, and A. G. Katopodis Cloning of a Human UDP-galactose:2-Acetamido-2-deoxy-D-glucose 3beta -Galactosyltransferase Catalyzing the Formation of Type 1 Chains J. Biol. Chem., January 2, 1998; 273(1): 433 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Salvini, A. Bardoni, M. Valli, and M. Trinchera beta 1,3-Galactosyltransferase beta 3Gal-T5 Acts on the GlcNAcbeta 1right-arrow3Galbeta 1right-arrow4GlcNAcbeta 1right-arrowR Sugar Chains of Carcinoembryonic Antigen and Other N-Linked Glycoproteins and Is Down-regulated in Colon Adenocarcinomas J. Biol. Chem., January 26, 2001; 276(5): 3564 - 3573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seko, S. Hara-Kuge, and K. Yamashita Molecular Cloning and Characterization of a Novel Human Galactose 3-O-Sulfotransferase That Transfers Sulfate to Galbeta 1right-arrow3GalNAc Residue in O-Glycans J. Biol. Chem., July 6, 2001; 276(28): 25697 - 25704. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |